Predict your next investment

Biosplice Therapeutics company logo
HEALTHCARE | Biotechnology
biosplice.com

See what CB Insights has to offer

Total Raised

$561.5M

Investors Count

10

Deal Terms

1

Biosplice Therapeutics Funding, Biosplice Therapeutics Valuation & Biosplice Therapeutics Revenue

6 Fundings

Biosplice Therapeutics's latest funding round was a Series B for $120M on April 15, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/15/2021

Series B

$120M

$0.00B

((9.99x))

FY 1234

2

4/27/2020

Loan

$99M

$0.00B

((9.99x))

FY 1234

10

8/6/2018

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

1/2/2012

Unattributed VC

$99M

$0.00B

((9.99x))

FY 1234

10

10/14/2008

Incubator/Accelerator

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/15/2021

4/27/2020

8/6/2018

1/2/2012

10/14/2008

Round

Series B

Loan

Series A

Unattributed VC

Incubator/Accelerator

Amount

$120M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

2

10

10

10

10

Biosplice Therapeutics Deal Terms

1 Deal Term

Biosplice Therapeutics's deal structure is available for 1 funding round, including their Series A from August 06, 2018.

Round

Series A

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

Biosplice Therapeutics Investors

10 Investors

Biosplice Therapeutics has 10 investors. Sands Capital invested in Biosplice Therapeutics's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/15/2021

4/15/2021

1
Series B

Venture Capital

Virginia

4/15/2021

4/15/2021

1
Series B

Corporation

DC

4/15/2021

4/15/2021

1
Series B

Asset/Investment Management

Connecticut

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Mutual Fund

Nebraska

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Israel

First funding

4/15/2021

4/15/2021

4/15/2021

00/00/0000

00/00/0000

Last Funding

4/15/2021

4/15/2021

4/15/2021

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

1
Series B
1
Series B
1
Series B

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Venture Capital

Corporation

Asset/Investment Management

Mutual Fund

Venture Capital

Location

Virginia

DC

Connecticut

Nebraska

Israel

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.